Catalyst Pharmaceuticals, Inc.
(NASDAQ : CPRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 1.50%72.295.6%$218.91m
CTLTCatalent, Inc. 0.34%93.792.1%$139.81m
VRXValeant Pharmaceuticals International, Inc. 0.68%19.3714.1%$113.98m
JAZZJazz Pharmaceuticals Plc -1.11%149.332.4%$83.31m
BHCBausch Health Cos., Inc. 0.62%19.360.0%$68.88m
SAGESAGE Therapeutics, Inc. 1.20%70.708.6%$66.22m
PRGOPerrigo Co. Plc 0.77%48.706.8%$58.32m
GWPHGW Pharmaceuticals Plc 0.56%137.206.1%$57.54m
ARGXargenx SE -0.49%285.360.0%$48.71m
UTHRUnited Therapeutics Corp. 0.13%130.1114.1%$46.29m
AMRNAmarin Corp. Plc 0.38%4.951.5%$41.71m
ICLRICON plc 0.28%199.894.2%$39.69m
SAVACassava Sciences, Inc. -0.94%7.420.0%$37.18m
CORTCorcept Therapeutics, Inc. -0.09%23.345.4%$32.82m
PCRXPacira Biosciences, Inc. 0.10%62.0910.0%$31.09m

Company Profile

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.